Results 271 to 280 of about 64,667 (338)

LncRNA ENST00000532153.1 alleviates podocyte injury by inhibiting PARP1-mediated PARylation of ATF3 in diabetic kidney disease. [PDF]

Cell Mol Life Sci
Yu Q, Yang M, Lu S, Su H, Liu Y, Zhang X, Fan X, Lv Z, Wang R.   +8 more
europepmc   +1 more source

The Lipid-Oxidative Stress Axis: Novel Therapeutic Targets for Podocytopathy. [PDF]

J Inflamm Res
Liu Y, Zou M, Wang Y.
europepmc   +1 more source

The Hippo pathway: potential target for immunotherapy of crescentic glomerulonephritis. [PDF]

Front Immunol
Kuang H, Cui Z, Zhao MH, Jia XY.
europepmc   +1 more source

Role of biophysics and mechanobiology in podocyte physiology

Jonathan C. Haydak, Evren U. Azeloglu
openalex   +2 more sources

Astragaloside IV Improves Diabetic Kidney Disease by Regulating NLRP3 Inflammasome. [PDF]

J Diabetes Res
Zhu H, Zheng L, Zhao K, Wang X, Ma Z, Zeng A, Zhao W, Zhang W, Han L, Huang Y.   +9 more
europepmc   +1 more source

Autophagy in the Pathogenesis of Membranous Nephropathy. [PDF]

Kidney Med
Ponticelli C, Reggiani F, Moroni G.
europepmc   +1 more source

Vincristine in FSGS: Rediscovering an Old Therapeutic for FSGS. [PDF]

Kidney Int Rep
Kumar A, Prasad P, Menon MC.
europepmc   +1 more source

Protein Inhibitor of Activated STAT2 Protects against Podocyte Injury in Diabetic Nephropathy via Inhibiting JAK2/STAT3 Pathway.

Kidney Blood Press Res
Li X, Zhang Y.
europepmc   +1 more source

Emerging roles of non-coding RNAs in idiopathic nephrotic syndrome: a narrative review. [PDF]

BMC Nephrol
Xu Z, Chen L, Wang Y, Yan L, Shao F, Liu F.   +5 more
europepmc   +1 more source

Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial. [PDF]

Ann Med
Nugroho P, Lydia A, Soewondo P, Suhardjono, Timan IS, Harimurti K, Ali Z.   +6 more
europepmc   +1 more source